Tenaya Therapeutics, Inc.

Direct answer

Tenaya Therapeutics, Inc. is publicly traded on NASDAQ under the ticker TNYA.

Tenaya Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. Its lead product candidate includes TN-201, a gene therapy for myosin binding protein C3-associated hypertrophic cardiomyopathy that is in Phase 1b/2 clinical trial; TN-401, a gene therapy for plakophilin 2-associated arrhythmogenic right ventricular cardiomyopathy,...

Can you invest in Tenaya Therapeutics, Inc.?

Yes. Tenaya Therapeutics, Inc. is publicly traded on NASDAQ under the ticker TNYA.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Tenaya Therapeutics, Inc.

Detailed equity research is provided by MarketSnap.